Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Logical Versus Absolute Lymphocyte Count-guided Preemptive Therapy for CMV Prevention in Solid Organ Transplant Recipients
TCTR20220720007Phase 3Completed
- Sponsor
- Faculty of Medicine Ramathibodi Hospital, Mahidol University
- Start
- Feb 2023
- Countries
- 1
01
Overview
Phase 3, randomised trial in cytomegalovirus disease (CMV) (2 arms), sponsored by Faculty of Medicine Ramathibodi Hospital, Mahidol University. Started Feb 2023; status: completed.
02
Conditions
cytomegalovirus disease (CMV)
Beyond the preview
Go deeper on TCTR20220720007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220720007.